The cells that mediate innate immune memory and their functional significance in inflammatory and infectious diseases

Seminars in Immunology

Volumn 28, Issue 4, 2016, Pages 343-350

  Gardiner, Clair M ^a   Mills, Kingston H G ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Infection; Inflammatory disease; Innate immune system; Memory; Monocyte macrophage; NK cell

Indexed keywords

CYTOKINE; LIPOPOLYSACCHARIDE; VACCINE; ANTIINFLAMMATORY AGENT; PATHOGEN ASSOCIATED MOLECULAR PATTERN;

ADAPTIVE IMMUNITY; BACTERIUM; CELL SPECIFICITY; CONTACT ALLERGY; CYTOKINE RESPONSE; CYTOMEGALOVIRUS; DENDRITIC CELL; EPIGENETICS; FUNGAL STRUCTURES; GAMMA DELTA T LYMPHOCYTE; HELMINTH; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; INFECTION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; REVIEW; ANIMAL; COMMUNICABLE DISEASE; GENETIC EPIGENESIS; IMMUNOLOGY; NUCLEAR REPROGRAMMING; VIROLOGY;

ADAPTIVE IMMUNITY; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELLULAR REPROGRAMMING; COMMUNICABLE DISEASES; EPIGENESIS, GENETIC; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; INFLAMMATION; KILLER CELLS, NATURAL; MACROPHAGES; MONOCYTES; PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES;

EID: 84960379805     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2016.03.001     Document Type: Review

References (74)

1. [1] Youmans, G.P., Youmans, A.S., Nonspecific factors in resistance of mice to experimental tuberculosis. J. Bacteriol. 90 (1965), 1675–1681.
2. [2] Poltorak, A., He, X., Smirnova, I., Liu, M.Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B., Beutler, B., Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998), 2085–2088.
3. [3] Akira, S., Uematsu, S., Takeuchi, O., Pathogen recognition and innate immunity. Cell 124 (2006), 783–801.
4. [4] Iglesias, M.J., Martin, C., Editorial commentary: Nonspecific beneficial effects of BCG vaccination in high-income countries, should we extend recommendation of BCG vaccination?. Clin. Infect. Dis. 60 (2015), 1620–1621.
5. [5] Brandau, S., Suttmann, H., Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement. Biomed. Pharmacother. 61 (2007), 299–305.
6. [6] Buffen, K., Oosting, M., Quintin, J., Ng, A., Kleinnijenhuis, J., Kumar, V., van de Vosse, E., Wijmenga, C., van Crevel, R., Oosterwijk, E., Grotenhuis, A.J., Vermeulen, S.H., Kiemeney, L.A., van de Veerdonk, F.L., Chamilos, G., Xavier, R.J., van der Meer, J.W., Netea, M.G., Joosten, L.A., Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer. PLoS Pathog., 10, 2014, e1004485.
7. [7] Cheng, S.C., Quintin, J., Cramer, R.A., Shepardson, K.M., Saeed, S., Kumar, V., Giamarellos-Bourboulis, E.J., Martens, J.H., Rao, N.A., Aghajanirefah, A., Manjeri, G.R., Li, Y., Ifrim, D.C., Arts, R.J., van der Veer, B.M., Deen, P.M., Logie, C., O'Neill, L.A., Willems, P., van de Veerdonk, F.L., van der Meer, J.W., Ng, A., Joosten, L.A., Wijmenga, C., Stunnenberg, H.G., Xavier, R.J., Netea, M.G., mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science, 345, 2014, 1250684.
8. [8] Saeed, S., Quintin, J., Kerstens, H.H., Rao, N.A., Aghajanirefah, A., Matarese, F., Cheng, S.C., Ratter, J., Berentsen, K., van der Ent, M.A., Sharifi, N., Janssen-Megens, E.M., Ter Huurne, M., Mandoli, A., van Schaik, T., Ng, A., Burden, F., Downes, K., Frontini, M., Kumar, V., Giamarellos-Bourboulis, E.J., Ouwehand, W.H., van der Meer, J.W., Joosten, L.A., Wijmenga, C., Martens, J.H., Xavier, R.J., Logie, C., Netea, M.G., Stunnenberg, H.G., Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science, 345, 2014, 1251086.
9. [9] Bianchi, M.E., DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81 (2007), 1–5.
10. [10] Kawai, T., Akira, S., The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11 (2010), 373–384.
11. [11] Manser, A.R., Weinhold, S., Uhrberg, M., Human KIR repertoires: shaped by genetic diversity and evolution. Immunol. Rev. 267 (2015), 178–196.
12. [12] Walsh, K.P., Mills, K.H., Dendritic cells and other innate determinants of T helper cell polarisation. Trends Immunol. 34 (2013), 521–530.
13. [13] Mills, K.H., TLR-dependent T cell activation in autoimmunity. Nat. Rev. Immunol. 11 (2011), 807–822.
14. [14] Quintin, J., Saeed, S., Martens, J.H., Giamarellos-Bourboulis, E.J., Ifrim, D.C., Logie, C., Jacobs, L., Jansen, T., Kullberg, B.J., Wijmenga, C., Joosten, L.A., Xavier, R.J., van der Meer, J.W., Stunnenberg, H.G., Netea, M.G., Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 12 (2012), 223–232.
15. [15] Netea, M.G., Quintin, J., van der Meer, J.W., Trained immunity: a memory for innate host defense. Cell Host Microbe 9 (2011), 355–361.
16. [16] Dobrovolskaia, M.A., Vogel, S.N., Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect. 4 (2002), 903–914.
17. [17] Foster, S.L., Hargreaves, D.C., Medzhitov, R., Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447 (2007), 972–978.
18. [18] Shi, D.W., Zhang, J., Jiang, H.N., Tong, C.Y., Gu, G.R., Ji, Y., Summah, H., Qu, J.M., LPS pretreatment ameliorates multiple organ injuries and improves survival in a murine model of polymicrobial sepsis. Inflamm. Res. 60 (2011), 841–849.
19. [19] Zhang, Y., Li, J., Lou, J., Zhou, Y., Bo, L., Zhu, J., Zhu, K., Wan, X., Cai, Z., Deng, X., Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients. Crit. Care, 15, 2011, R70.
20. [20] Hotchkiss, R.S., Monneret, G., Payen, D., Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13 (2013), 862–874.
21. [21] Hutchins, N.A., Wang, F., Wang, Y., Chung, C.S., Ayala, A., Kupffer cells potentiate liver sinusoidal endothelial cell injury in sepsis by ligating programmed cell death ligand-1. J. Leukoc. Biol. 94 (2013), 963–970.
22. [22] Finlay, C.M., Stefanska, A.M., Walsh, K.P., Kelly, P.J., Boon, L., Lavelle, E.C., Walsh, P.T., Mills, K.H.G., Helminth products protect against autoimmunity via innate type 2 cytokines IL-5 and IL-33, which promote eosinophilia. J. Immunol. 196 (2016), 703–714.
23. [23] Finlay, C.M., Walsh, K.P., Mills, K.H., Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases. Immunol. Rev. 259 (2014), 206–230.
24. [24] Li, R., Lim, A., Phoon, M.C., Narasaraju, T., Ng, J.K., Poh, W.P., Sim, M.K., Chow, V.T., Locht, C., Alonso, S., Attenuated Bordetella pertussis protects against highly pathogenic influenza A viruses by dampening the cytokine storm. J. Virol. 84 (2010), 7105–7113.
25. [25] Li, R., Cheng, C., Chong, S.Z., Lim, A.R., Goh, Y.F., Locht, C., Kemeny, D.M., Angeli, V., Wong, W.S., Alonso, S., Attenuated Bordetella pertussis BPZE1 protects against allergic airway inflammation and contact dermatitis in mouse models. Allergy 67 (2012), 1250–1258.
26. [26] Edwards, S.C., Higgins, S.C., Mills, K.H., Respiratory infection with a bacterial pathogen attenuates CNS autoimmunity through IL-10 induction. Brain Behav. Immun. 50 (2015), 41–46.
27. [27] McGuirk, P., McCann, C., Mills, K.H., Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195 (2002), 221–231.
28. [28] Butt, A.Q., Mills, K.H., Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines. Oncogene 33 (2014), 4623–4631.
29. [29] Long, E.O., Kim, H.S., Liu, D., Peterson, M.E., Rajagopalan, S., Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu. Rev. Immunol. 31 (2013), 227–258.
30. [30] Sun, J.C., Beilke, J.N., Lanier, L.L., Immune memory redefined: characterizing the longevity of natural killer cells. Immunol. Rev. 236 (2010), 83–94.
31. [31] Bjorkstrom, N.K., Lindgren, T., Stoltz, M., Fauriat, C., Braun, M., Evander, M., Michaelsson, J., Malmberg, K.J., Klingstrom, J., Ahlm, C., Ljunggren, H.G., Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 208 (2011), 13–21.
32. [32] Kleinnijenhuis, J., Quintin, J., Preijers, F., Joosten, L.A., Jacobs, C., Xavier, R.J., van der Meer, J.W., van Crevel, R., Netea, M.G., BCG-induced trained immunity in NK cells: role for non-specific protection to infection. Clin. Immunol. 155 (2014), 213–219.
33. [33] Dou, Y., Fu, B., Sun, R., Li, W., Hu, W., Tian, Z., Wei, H., Influenza vaccine induces intracellular immune memory of human NK cells. PLoS One, 10, 2015, e0121258.
34. [34] Cudkowicz, G., Stimpfling, J.H., Induction of immunity and of unresponsiveness to parental marrow grafts in adult F-1 hybrid mice. Nature 204 (1964), 450–453.
35. [35] Bennett, M., Yu, Y.Y., Stoneman, E., Rembecki, R.M., Mathew, P.A., Lindahl, K.F., Kumar, V., Hybrid resistance: ‘negative’ and ‘positive’ signaling of murine natural killer cells. Semin. Immunol. 7 (1995), 121–127.
36. [36] Bukowski, J.F., Woda, B.A., Welsh, R.M., Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J. Virol. 52 (1984), 119–128.
37. [37] Webb, J.R., Lee, S.H., Vidal, S.M., Genetic control of innate immune responses against cytomegalovirus: MCMV meets its match. Genes Immun. 3 (2002), 250–262.
38. [38] Paust, S., Gill, H.S., Wang, B.Z., Flynn, M.P., Moseman, E.A., Senman, B., Szczepanik, M., Telenti, A., Askenase, P.W., Compans, R.W., von Andrian, U.H., Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat. Immunol. 11 (2010), 1127–1135.
39. [39] Brodin, P., Jojic, V., Gao, T., Bhattacharya, S., Angel, C.J., Furman, D., Shen-Orr, S., Dekker, C.L., Swan, G.E., Butte, A.J., Maecker, H.T., Davis, M.M., Variation in the human immune system is largely driven by non-heritable influences. Cell 160 (2015), 37–47.
40. [40] Lopez-Botet, M., Angulo, A., Guma, M., Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. Tissue Antigens 63 (2004), 195–203.
41. [41] Lopez-Verges, S., Milush, J.M., Schwartz, B.S., Pando, M.J., Jarjoura, J., York, V.A., Houchins, J.P., Miller, S., Kang, S.M., Norris, P.J., Nixon, D.F., Lanier, L.L., Expansion of a unique CD57(+)NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 14725–14732.
42. [42] Foley, B., Cooley, S., Verneris, M.R., Curtsinger, J., Luo, X., Waller, E.K., Anasetti, C., Weisdorf, D., Miller, J.S., Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen. J. Immunol. 189 (2012), 5082–5088.
43. [43] Guma, M., Angulo, A., Vilches, C., Gomez-Lozano, N., Malats, N., Lopez-Botet, M., Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104 (2004), 3664–3671.
44. [44] Muntasell, A., Vilches, C., Angulo, A., Lopez-Botet, M., Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction. Eur. J. Immunol. 43 (2013), 1133–1141.
45. [45] Lee, J., Zhang, T., Hwang, I., Kim, A., Nitschke, L., Kim, M., Scott, J.M., Kamimura, Y., Lanier, L.L., Kim, S., Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals. Immunity 42 (2015), 431–442.
46. [46] Schlums, H., Cichocki, F., Tesi, B., Theorell, J., Beziat, V., Holmes, T.D., Han, H., Chiang, S.C., Foley, B., Mattsson, K., Larsson, S., Schaffer, M., Malmberg, K.J., Ljunggren, H.G., Miller, J.S., Bryceson, Y.T., Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity 42 (2015), 443–456.
47. [47] Nielsen, C.M., White, M.J., Bottomley, C., Lusa, C., Rodriguez-Galan, A., Turner, S.E., Goodier, M.R., Riley, E.M., Impaired NK cell responses to pertussis and H1N1 influenza vaccine antigens in human cytomegalovirus-infected individuals. J. Immunol. 194 (2015), 4657–4667.
48. [48] Moraru, M., Black, L.E., Muntasell, A., Portero, F., Lopez-Botet, M., Reyburn, H.T., Pandey, J.P., Vilches, C., NK cell and Ig interplay in defense against herpes simplex virus type 1: epistatic interaction of CD16A and IgG1 allotypes of variable affinities modulates antibody-dependent cellular cytotoxicity and susceptibility to clinical reactivation. J. Immunol. 195 (2015), 1676–1684.
49. [49] O'Leary, J.G., Goodarzi, M., Drayton, D.L., von Andrian, U.H., T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 7 (2006), 507–516.
50. [50] Cooper, M.A., Elliott, J.M., Keyel, P.A., Yang, L., Carrero, J.A., Yokoyama, W.M., Cytokine-induced memory-like natural killer cells. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 1915–1919.
51. [51] Romee, R., Schneider, S.E., Leong, J.W., Chase, J.M., Keppel, C.R., Sullivan, R.P., Cooper, M.A., Fehniger, T.A., Cytokine activation induces human memory-like NK cells. Blood 120 (2012), 4751–4760.
52. [52] Teirlinck, A.C., McCall, M.B., Roestenberg, M., Scholzen, A., Woestenenk, R., de Mast, Q., van der Ven, A.J., Hermsen, C.C., Luty, A.J., Sauerwein, R.W., Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS Pathog., 7, 2011, e1002389.
53. [53] McCall, M.B., Roestenberg, M., Ploemen, I., Teirlinck, A., Hopman, J., de Mast, Q., Dolo, A., Doumbo, O.K., Luty, A., van der Ven, A.J., Hermsen, C.C., Sauerwein, R.W., Memory-like IFN-gamma response by NK cells following malaria infection reveals the crucial role of T cells in NK cell activation by P. falciparum. Eur. J. Immunol. 40 (2010), 3472–3477.
54. [54] Horowitz, A., Hafalla, J.C., King, E., Lusingu, J., Dekker, D., Leach, A., Moris, P., Cohen, J., Vekemans, J., Villafana, T., Corran, P.H., Bejon, P., Drakeley, C.J., von Seidlein, L., Riley, E.M., Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine. J. Immunol. 188 (2012), 5054–5062.
55. [55] Reeves, R.K., Li, H., Jost, S., Blass, E., Li, H., Schafer, J.L., Varner, V., Manickam, C., Eslamizar, L., Altfeld, M., von Andrian, U.H., Barouch, D.H., Antigen-specific NK cell memory in rhesus macaques. Nat. Immunol. 16 (2015), 927–932.
56. [56] Beaulieu, A.M., Zawislak, C.L., Nakayama, T., Sun, J.C., The transcription factor Zbtb32 controls the proliferative burst of virus-specific natural killer cells responding to infection. Nat. Immunol. 15 (2014), 546–553.
57. [57] Donnelly, R.P., Loftus, R.M., Keating, S.E., Liou, K.T., Biron, C.A., Gardiner, C.M., Finlay, D.K., mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function. J. Immunol. 193 (2014), 4477–4484.
58. [58] Keppel, M.P., Saucier, N., Mah, A.Y., Vogel, T.P., Cooper, M.A., Activation-specific metabolic requirements for NK Cell IFN-gamma production. J. Immunol. 194 (2015), 1954–1962.
59. [59] Marcais, A., Cherfils-Vicini, J., Viant, C., Degouve, S., Viel, S., Fenis, A., Rabilloud, J., Mayol, K., Tavares, A., Bienvenu, J., Gangloff, Y.G., Gilson, E., Vivier, E., Walzer, T., The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat. Immunol. 15 (2014), 749–757.
60. [60] Cortez, V.S., Fuchs, A., Cella, M., Gilfillan, S., Colonna, M., Cutting edge: salivary gland NK cells develop independently of Nfil3 in steady-state. J. Immunol. 192 (2014), 4487–4491.
61. [61] Peng, H., Jiang, X., Chen, Y., Sojka, D.K., Wei, H., Gao, X., Sun, R., Yokoyama, W.M., Tian, Z., Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J. Clin. Investig. 123 (2013), 1444–1456.
62. [62] Sojka, D.K., Plougastel-Douglas, B., Yang, L., Pak-Wittel, M.A., Artyomov, M.N., Ivanova, Y., Zhong, C., Chase, J.M., Rothman, P.B., Yu, J., Riley, J.K., Zhu, J., Tian, Z., Yokoyama, W.M., Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells. eLife, 3, 2014, e01659.
63. [63] Fowler, D.W., Copier, J., Wilson, N., Dalgleish, A.G., Bodman-Smith, M.D., Mycobacteria activate gammadelta T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy. Cancer Immunol. Immunother. 61 (2012), 535–547.
64. [64] Takeuchi, A., Dejima, T., Yamada, H., Shibata, K., Nakamura, R., Eto, M., Nakatani, T., Naito, S., Yoshikai, Y., IL-17 production by gammadelta T cells is important for the antitumor effect of Mycobacterium bovis bacillus Calmette-Guerin treatment against bladder cancer. Eur. J. Immunol. 41 (2011), 246–251.
65. [65] Rei, M., Goncalves-Sousa, N., Lanca, T., Thompson, R.G., Mensurado, S., Balkwill, F.R., Kulbe, H., Pennington, D.J., Silva-Santos, B., Murine CD27(−) Vgamma6(+) gammadelta T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), E3562–E3570.
66. [66] Murphy, A.G., O'Keeffe, K.M., Lalor, S.J., Maher, B.M., Mills, K.H., McLoughlin, R.M., Staphylococcus aureus infection of mice expands a population of memory gammadelta T cells that are protective against subsequent infection. J. Immunol. 192 (2014), 3697–3708.
67. [67] Sutton, C.E., Lalor, S.J., Sweeney, C.M., Brereton, C.F., Lavelle, E.C., Mills, K.H., Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31 (2009), 331–341.
68. [68] Lalor, S.J., Dungan, L.S., Sutton, C.E., Basdeo, S.A., Fletcher, J.M., Mills, K.H., Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity. J. Immunol. 186 (2011), 5738–5748.
69. [69] Cai, Y., Shen, X., Ding, C., Qi, C., Li, K., Li, X., Jala, V.R., Zhang, H.G., Wang, T., Zheng, J., Yan, J., Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation. Immunity 35 (2011), 596–610.
70. [70] Conti, H.R., Peterson, A.C., Brane, L., Huppler, A.R., Hernandez-Santos, N., Whibley, N., Garg, A.V., Simpson-Abelson, M.R., Gibson, G.A., Mamo, A.J., Osborne, L.C., Bishu, S., Ghilardi, N., Siebenlist, U., Watkins, S.C., Artis, D., McGeachy, M.J., Gaffen, S.L., Oral-resident natural Th17 cells and gammadelta T cells control opportunistic Candida albicans infections. J. Exp. Med. 211 (2014), 2075–2084.
71. [71] Benn, C.S., Netea, M.G., Selin, L.K., Aaby, P., A small jab – a big effect: nonspecific immunomodulation by vaccines. Trends Immunol. 34 (2013), 431–439.
72. [72] Baumert, T.F., Fauvelle, C., Chen, D.Y., Lauer, G.M., A prophylactic hepatitis C virus vaccine: a distant peak still worth climbing. J. Hepatol. 61 (2014), S34–S44.
73. [73] Kopanakis, K., Tzepi, I.M., Pistiki, A., Carrer, D.P., Netea, M.G., Georgitsi, M., Lymperi, M., Droggiti, D.I., Liakakos, T., Machairas, A., Giamarellos-Bourboulis, E.J., Pre-treatment with low-dose endotoxin prolongs survival from experimental lethal endotoxic shock: benefit for lethal peritonitis by Escherichia coli. Cytokine 62 (2013), 382–388.
74. [74] Summers, R.W., Elliott, D.E., Urban, J.F. Jr., Thompson, R., Weinstock, J.V., Trichuris suis therapy in Crohn's disease. Gut 54 (2005), 87–90.